Jan. 21 at 5:11 PM
$BDSX
Ran the acquisition subject by AI-
An acquisition by Thermo Fisher Scientific (TMO) can absolutely make sense strategically, and in fact TMO has been actively doing exactly that with multiple deals recently. Its strategy clearly prioritizes expansion into adjacent diagnostics, clinical research services, data/technology platforms, and biopharma support, all of which strengthen its core life-science tools business and broaden long-term growth.
$25 +++🧲🧲🧲🧲
